Dinavahi SS - Search Results

1

Aldehyde Dehydrogenase Inhibitors for Cancer Therapeutics.

Dinavahi SS, Bazewicz CG, Gowda R, Robertson GP. Dinavahi SS, et al. Trends Pharmacol Sci. 2019 Oct;40(10):774-789. doi: 10.1016/j.tips.2019.08.002. Epub 2019 Sep 9. Trends Pharmacol Sci. 2019. PMID: 31515079 Review.

2

Aldehyde dehydrogenase in regulatory T-cell development, immunity and cancer.

Bazewicz CG, Dinavahi SS, Schell TD, Robertson GP. Bazewicz CG, et al. Among authors: dinavahi ss. Immunology. 2019 Jan;156(1):47-55. doi: 10.1111/imm.13016. Epub 2018 Nov 22. Immunology. 2019. PMID: 30387499 Free PMC article. Review.

3

Development of a Novel Multi-Isoform ALDH Inhibitor Effective as an Antimelanoma Agent.

Dinavahi SS, Gowda R, Gowda K, Bazewicz CG, Chirasani VR, Battu MB, Berg A, Dokholyan NV, Amin S, Robertson GP. Dinavahi SS, et al. Mol Cancer Ther. 2020 Feb;19(2):447-459. doi: 10.1158/1535-7163.MCT-19-0360. Epub 2019 Nov 21. Mol Cancer Ther. 2020. PMID: 31754071 Free PMC article.

4

Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents.

Dinavahi SS, Gowda R, Bazewicz CG, Battu MB, Lin JM, Chitren RJ, Pandey MK, Amin S, Robertson GP, Gowda K. Dinavahi SS, et al. Eur J Med Chem. 2020 Feb 1;187:111962. doi: 10.1016/j.ejmech.2019.111962. Epub 2019 Dec 12. Eur J Med Chem. 2020. PMID: 31887569

5

Salubrinal in Combination With 4E1RCat Synergistically Impairs Melanoma Development by Disrupting the Protein Synthetic Machinery.

Kardos GR, Gowda R, Dinavahi SS, Kimball S, Robertson GP. Kardos GR, et al. Among authors: dinavahi ss. Front Oncol. 2020 Jun 19;10:834. doi: 10.3389/fonc.2020.00834. eCollection 2020. Front Oncol. 2020. PMID: 32637352 Free PMC article.

6

Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport.

Gowda R, Inamdar GS, Kuzu O, Dinavahi SS, Krzeminski J, Battu MB, Voleti SR, Amin S, Robertson GP. Gowda R, et al. Among authors: dinavahi ss. Oncotarget. 2017 Apr 25;8(17):28260-28277. doi: 10.18632/oncotarget.16002. Oncotarget. 2017. PMID: 28423677 Free PMC article.

7

Improving pharmacological targeting of AKT in melanoma.

Kuzu OF, Gowda R, Sharma A, Noory MA, Dinavahi SS, Kardos G, Drabick JJ, Robertson GP. Kuzu OF, et al. Among authors: dinavahi ss. Cancer Lett. 2017 Sep 28;404:29-36. doi: 10.1016/j.canlet.2017.07.001. Epub 2017 Jul 11. Cancer Lett. 2017. PMID: 28705772

8

Moving Synergistically Acting Drug Combinations to the Clinic by Comparing Sequential versus Simultaneous Drug Administrations.

Dinavahi SS, Noory MA, Gowda R, Drabick JJ, Berg A, Neves RI, Robertson GP. Dinavahi SS, et al. Mol Pharmacol. 2018 Mar;93(3):190-196. doi: 10.1124/mol.117.110759. Epub 2017 Dec 14. Mol Pharmacol. 2018. PMID: 29242354 Free PMC article.

9

Nanoliposomal delivery of cytosolic phospholipase A₂ inhibitor arachidonyl trimethyl ketone for melanoma treatment.

Gowda R, Dinavahi SS, Iyer S, Banerjee S, Neves RI, Pameijer CR, Robertson GP. Gowda R, et al. Among authors: dinavahi ss. Nanomedicine. 2018 Apr;14(3):863-873. doi: 10.1016/j.nano.2017.12.020. Epub 2018 Jan 6. Nanomedicine. 2018. PMID: 29317343 Free PMC article.

10

The role of exosomes in metastasis and progression of melanoma.

Gowda R, Robertson BM, Iyer S, Barry J, Dinavahi SS, Robertson GP. Gowda R, et al. Among authors: dinavahi ss. Cancer Treat Rev. 2020 Apr;85:101975. doi: 10.1016/j.ctrv.2020.101975. Epub 2020 Jan 22. Cancer Treat Rev. 2020. PMID: 32050108 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page